{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:43:43Z","timestamp":1785163423418,"version":"3.55.0"},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"3","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["A19H040480"],"award-info":[{"award-number":["A19H040480"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04111"],"award-info":[{"award-number":["JP17H04111"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0400","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:07:57Z","timestamp":1763071677000},"page":"383-397","source":"Crossref","is-referenced-by-count":1,"title":["Association of HLA-DRB1 pocket structures with susceptibility and prognosis of Graves\u2019 and Hashimoto\u2019s disease"],"prefix":"10.1507","volume":"73","author":[{"given":"Yusuke","family":"Noguchi","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6058-5938","authenticated-orcid":false,"given":"Yuya","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"},{"name":"Laboratory for Clinical Investigation, The University of Osaka Hospital, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisa","family":"Inaoka","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical Investigation, The University of Osaka Hospital, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4371-0398","authenticated-orcid":false,"given":"Yoshinori","family":"Iwatani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-9296","authenticated-orcid":false,"given":"Mikio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Jacobson EM, Tomer Y (2007) The genetic basis of thyroid autoimmunity. Thyroid 17: 949\u2013961.","DOI":"10.1089\/thy.2007.0153"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Weetman AP (2004) Autoimmune thyroid disease. Autoimmunity 37: 337\u2013340.","DOI":"10.1080\/08916930410001705394"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, et al. (2014) Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab 99: E379\u2013E383.","DOI":"10.1210\/jc.2013-2841"},{"key":"4","unstructured":"4 Dong YH, Fu DG (2014) Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci 18: 3611\u20133618."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Jones EY, Fugger L, Strominger JL, Siebold C (2006) MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6: 271\u2013282.","DOI":"10.1038\/nri1805"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, et al. (2004) Gene map of the extended human MHC. Nat Rev Genet 5: 889\u2013899.","DOI":"10.1038\/nrg1489"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Naito T, Okada Y (2022) HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases. Semin Immunopathol 44: 15\u201328.","DOI":"10.1007\/s00281-021-00901-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, et al. (2010) Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 107: 16899\u201316903.","DOI":"10.1073\/pnas.1009511107"},{"key":"9","unstructured":"9 Nelson JL, Hansen JA (1990) Autoimmune diseases and HLA. Crit Rev Immunol 10: 307\u2013328."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Faas S, Trucco M (1994) The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 17: 477\u2013495.","DOI":"10.1007\/BF03347743"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Menconi F, Monti MC, Greenberg DA, Oashi T, Osman R, et al. (2008) Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A 105: 14034\u201314039.","DOI":"10.1073\/pnas.0806584105"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Zeitlin AA, Heward JM, Newby PR, Carr-Smith JD, Franklyn JA, et al. (2008) Analysis of HLA class II genes in Hashimoto\u2019s thyroiditis reveals differences compared to Graves\u2019 disease. Genes Immun 9: 358\u2013363.","DOI":"10.1038\/gene.2008.26"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, et al. (2009) Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes\u2019 associations of Hashimoto\u2019s thyroiditis in a Greek population. Tissue Antigens 73: 199\u2013205.","DOI":"10.1111\/j.1399-0039.2008.01182.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Cho WK, Jung MH, Choi EJ, Choi HB, Kim TG, et al. (2011) Association of HLA alleles with autoimmune thyroid disease in Korean children. Horm Res Paediatr 76: 328\u2013334.","DOI":"10.1159\/000331134"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Katsuren E, Awata T, Matsumoto C, Yamamoto K (1994) HLA class II alleles in Japanese patients with Graves\u2019 disease: weak associations of HLA-DR and -DQ. Endocr J 41: 599\u2013603.","DOI":"10.1507\/endocrj.41.599"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ (2000) Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 95: 432\u2013437.","DOI":"10.1002\/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Huang SM, Wu TJ, Lee TD, Yang EK, Shaw CK, et al. (2003) The association of HLA -A, -B, and -DRB1 genotypes with Graves\u2019 disease in Taiwanese people. Tissue Antigens 61: 154\u2013158.","DOI":"10.1034\/j.1399-0039.2003.00016.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Iwama S, Ikezaki A, Kikuoka N, Kim HS, Matsuoka H, et al. (2005) Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves\u2019 disease in Japanese children. Horm Res 63: 55\u201360.","DOI":"10.1159\/000083137"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Katahira M, Hanakita M, Ito T, Suzuki M (2013) Effect of human leukocyte antigen class II genes on Hashimoto\u2019s thyroiditis requiring replacement therapy with levothyroxine in the Japanese population. Hum Immunol 74: 607\u2013609.","DOI":"10.1016\/j.humimm.2013.01.026"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Jacobson EM, Huber A, Tomer Y (2008) The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30: 58\u201362.","DOI":"10.1016\/j.jaut.2007.11.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Katahira M, Ogata H, Takashima H, Ito T, Hodai Y, et al. (2021) Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves\u2019 disease and Hashimoto\u2019s thyroiditis in the Japanese population. Hum Immunol 82: 226\u2013231.","DOI":"10.1016\/j.humimm.2020.12.007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, et al. (2004) Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves\u2019 disease. Genes Immun 5: 203\u2013208.","DOI":"10.1038\/sj.gene.6364059"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, et al. (2015) Construction of a population-specific HLA imputation reference panel and its application to Graves\u2019 disease risk in Japanese. Nat Genet 47: 798\u2013802.","DOI":"10.1038\/ng.3310"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kiani J, Hajilooi M, Furst D, Rezaei H, Shahryari-Hesami S, et al. (2015) HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population. Int J Immunogenet 42: 279\u2013286.","DOI":"10.1111\/iji.12216"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Katahira M, Tsunekawa T, Mizoguchi A, Yamaguchi M, Tsuru K, et al. (2021) Critical amino acid variants in HLA-DRB1 and -DQB1 allotypes in the development of classical type 1 diabetes and latent autoimmune diabetes in adults in the Japanese population. Curr Issues Mol Biol 43: 107\u2013115.","DOI":"10.3390\/cimb43010009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Greer JM, Pender MP (2005) The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 656\u2013662.","DOI":"10.1136\/jnnp.2004.042168"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Akel O, Zhao LP, Geraghty DE, Lind A (2022) High-resolution HLA class II sequencing of Swedish multiple sclerosis patients. Int J Immunogenet 49: 333\u2013339.","DOI":"10.1111\/iji.12594"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Freed BM, Schuyler RP, Aubrey MT (2011) Association of the HLA-DRB1 epitope LA(67, 74) with rheumatoid arthritis and citrullinated vimentin binding. Arthritis Rheum 63: 3733\u20133739.","DOI":"10.1002\/art.30636"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Oka S, Furukawa H, Kawasaki A, Shimada K, Sugii S, et al. (2014) Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One 9: e99453.","DOI":"10.1371\/journal.pone.0099453"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Vald\u00e9s-Corona LF, Hern\u00e1ndez-Do\u00f1o S, Rodr\u00edguez-Reyna TS, Garc\u00eda-Silva R, Jakez J, et al. (2020) Aspartic acid(70) in the HLA-DRB1 chain and shared epitope alleles partially explain the high prevalence of autoimmunity in Mexicans. J Transl Autoimmun 3: 100057.","DOI":"10.1016\/j.jtauto.2020.100057"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Inoue M, Nagafuchi Y, Ota M, Tsuchiya H, Tateishi S, et al. (2023) Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis. Sci Rep 13: 15250.","DOI":"10.1038\/s41598-023-42324-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Furukawa H, Oka S, Tsuchiya N, Shimada K, Hashimoto A, et al. (2017) The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases. Genes Immun 18: 1\u20137.","DOI":"10.1038\/gene.2016.40"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Molineros JE, Looger LL, Kim K, Okada Y, Terao C, et al. (2019) Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians. PLoS Genet 15: e1008092.","DOI":"10.1371\/journal.pgen.1008092"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Rana RS, Naik B, Yadav M, Singh U, Singh A, et al. (2023) Role of HLA alleles polymorphism in systemic lupus erythematosus: a prospective study from North India. Indian J Pathol Microbiol 66: 545\u2013548.","DOI":"10.4103\/ijpm.ijpm_764_21"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Park MH, Park YJ, Song EY, Park H, Kim TY, et al. (2005) Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 66: 741\u2013747.","DOI":"10.1016\/j.humimm.2005.03.001"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36 Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, et al. (2015) Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens 85: 252\u2013259.","DOI":"10.1111\/tan.12536"},{"key":"37","unstructured":"37 EMBL-EBI Immuno Polymorphism Database-IMGT\/HLA. https:\/\/www.ebi.ac.uk\/ipd\/imgt\/hla\/alignment\/ accessed on June 17, 2020."},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225\u2013235.","DOI":"10.1111\/j.1399-0039.1992.tb01940.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Kotsch K, Wehling J, Blasczyk R (1999) Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 53: 486\u2013497.","DOI":"10.1034\/j.1399-0039.1999.530505.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175\u2013191.","DOI":"10.3758\/BF03193146"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779\u2013815.","DOI":"10.1006\/jmbi.1993.1626"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25: 1605\u20131612.","DOI":"10.1002\/jcc.20084"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43 Bondinas GP, Moustakas AK, Papadopoulos GK (2007) The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function. Immunogenetics 59: 539\u2013553.","DOI":"10.1007\/s00251-007-0224-8"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, et al. (2010) Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun 35: 45\u201351.","DOI":"10.1016\/j.jaut.2010.01.004"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Muix\u00ed L, Carrascal M, Alvarez I, Daura X, Mart\u00ed M, et al. (2008) Thyroglobulin peptides associate <i>in vivo<\/i> to HLA-DR in autoimmune thyroid glands. J Immunol 181: 795\u2013807.","DOI":"10.4049\/jimmunol.181.1.795"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Jacobson EM, Yang H, Menconi F, Wang R, Osman R, et al. (2009) Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem 284: 34231\u201334243.","DOI":"10.1074\/jbc.M109.041574"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, et al. (2004) Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol 229: 79\u201385.","DOI":"10.1016\/j.cellimm.2004.07.002"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/3\/73_EJ25-0400\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:50:51Z","timestamp":1772855451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/3\/73_EJ25-0400\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0400","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0400"}}